Cent Eur J Public Health 2003, 11(Supplement):S42-S49

The 2001 serological survey in the Czech Republic - Rubella

Mrázová M.1, ©melhausová M.1, ©estáková Z.1, ©vandová E.2, Beneą Č.3
1 Centre of Epidemiology and Microbiology, NRL for mumps, measles and rubella
2 Centre of Biostatics and Informatistics
3 Centre of Epidemiology and Microbiology, NCR for analysis of epidemiological data, National Institute of Public Health, Prague, Czech Republic

In total, 3,009 sera from a representative population sample of the Czech Republic, 1508 females and 1,501 males, were tested by EIA using a commercial kit ETI-RUBEK-G Plus manufactured by Dia Sorin, Italy. The vaccination strategy was as follows: vaccination of 12-year-old girls since 1982 and all 2-yearolds vaccinated since 1986. Currently, all women under 31 years of age and all men under 17 years of age have been vaccinated. The results of the serological survey confirmed lower seropositivity rates in young men compared to vaccinated women of the same age as expected. An epidemic outbreak of rubeola among young men is another evidence of that. The seropositivity rate of 2- 9-year-old vaccinee children reaches almost 95 %. The long-term morbidity trend in the Czech Republic is downward sloping, with a marked differentiation between the male and female populations.

Klíčová slova: rubella, serological survey, vaccination, herd immunity, post-vaccination immunity

Zveřejněno: 1. prosinec 2003  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mrázová M, ©melhausová M, ©estáková Z, ©vandová E, Beneą Č. The 2001 serological survey in the Czech Republic - Rubella. Cent Eur J Public Health. 2003;11(Supplement):S42-49. PubMed PMID: 15080259.
Stáhnout citaci